Logos Global Management »

Xencor shares owned by Logos Global Management

Quarter-by-quarter ownership of Xencor (XNCR) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Xencor

Tip: Access up to 7 years of quarterly data

All positions including Xencor held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xencor by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $14M 650k 22.13

More positions owned by Logos Global Management

Sarepta Therapeutics (SRPT)
Alnylam Pharmaceuticals Call Option (ALNY)
Ideaya Biosciences (IDYA)
Immunocore Hldgs Ads (IMCR)
Immunovant (IMVT)
Ocular Therapeutix (OCUL)
Structure Therapeutics Sponsored Ads (GPCR)
Olema Pharmaceuticals (OLMA)
Dyne Therapeutics (DYN)
Apellis Pharmaceuticals (APLS)
Rocket Pharmaceuticals (RCKT)
Astria Therapeutics Call Option (ATXS)
Silence Therapeutics Ads (SLN)
Geron Corporation (GERN)
Annexon (ANNX)

View all positions for Logos Global Management

Top funds holding Xencor

BlackRock
PRIMECAP Management Company
Vanguard Group
EcoR1 Capital
T. Rowe Price Associates
Dimensional Fund Advisors
Geode Capital Management
Darwin Global Management
Armistice Capital
Loomis, Sayles and
Point72 Asset Management
Millennium Management
Morgan Stanley
Johnson & Johnson
Northern Trust

View all funds holding Xencor